ASS1 and urinary bladder cancer: Argininosuccinate synthase 1 (ASS1) in cisplatin-resistant bladder cancer cells is hypermethylated, resulting in greatly downregulated expression, suppressing the apoptotic effects of cisplatin (Yeon et al., 2018).